HC Wainwright reaffirmed their buy rating on shares of Immuron Limited – American Depositary Shares (NASDAQ:IMRN) in a research note released on Friday morning. The brokerage currently has a $20.00 target price on the stock.
Immuron Limited – American Depositary Shares (IMRN) traded down $2.34 during trading on Friday, hitting $11.35. 64,704 shares of the stock traded hands, compared to its average volume of 19,161. Immuron Limited – American Depositary Shares has a 52-week low of $4.47 and a 52-week high of $16.70.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3253592/immuron-limited-american-depositary-shares-imrn-buy-rating-reaffirmed-at-hc-wainwright.html.
About Immuron Limited – American Depositary Shares
Immuron Limited, a microbiome company, focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. It has a technology platform that enables a shorter development therapeutic cycle.
Receive News & Ratings for Immuron Limited - American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immuron Limited - American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.